SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Bezos Earth rules out $30 million investment in Israeli alternative protein center due to war

Wake up! US Jewry must act now

"I prefer to be unemployed than continue working at a university with Hamas supporters"

Full list of Israeli startup M&As in 2024

Buzz

Most popular

Daily

Weekly

1

Nvidia on verge of completing $700 million acquisition of Run:ai

2

Nvidia announces $700 million acquisition of Run:ai

3

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

4

Nagomi Security raises $23 million Series A for proactive defense platform

5

Bill Ackman: "Israel needs support more than ever and I can help"

Multiple Sclerosis

2 stories about Multiple Sclerosis

ה מטה הנוכחי של טבע ב ארה"ב

Mylan Cuts Price of Generic Copaxone Offering by 60%

11.07.18|Lilach Baumer

Mylan has achieved a 15%-20% market share in the U.S. since launching its generic version in late 2017 with a monthly price tag of $5,000, compared to Teva's $5,800

Former Teva Executive One Step Closer to Bringing Copaxone Rival to Market

31.10.17|Lilach Baumer

Mapi Pharma announced a successful phase II clinical trial for its Copaxone equivalent GA Depot